journal article·2012-12-28

Evaluation of Ti implants coated with Ag-containing borate bioactive glass for simultaneous eradication of infection and fracture fixation in a rabbit tibial model

Wei Xiao, Shi-Hua Luo, Xiao-Juan Wei, Chang-Qing Zhang, Wen-Hai Huang, Jia-Kang Chen, Yong Cai, Yong Rui, Mohamed N. Rahaman

Journal of Materials Research· Volume 27· Issue 24
Publisher page

Abstract

The ability of silver (Ag)-containing borate bioactive glass (BG) coatings to improve the biocompatibility and antibacterial properties of titanium (Ti) implants was investigated in vitro and in vivo in a rabbit tibial fracture model. Dense coatings of borate BG (thickness ≈ 20 μm) containing 0, 0.75, and 1.0 wt% Ag2O were prepared by depositing a layer of particles on Ti plates, followed by sintering at 900 °C. The as-prepared coatings had an adhesive strength of 10 ± 1 MPa, and when immersed in an aqueous phosphate (K2HPO4) solution, the coatings converted to hydroxyapatite, releasing Ag+ions continuously for over 4 wk. After implantation of BG-coated Ti constructs in a rabbit tibial fracture model and of methicillin-resistant Staphylococcus aureus-induced osteomyelitis, the BG coating doped with 1.0 wt% Ag2O was most effective for the simultaneous eradication of the infection and fracture fixation. Implants coated with Ag-containing BG coatings could provide an approach for reducing implant-related bone infection.
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Facial Trauma and Fracture Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (38)

Show source-provided references
1. 10.1002/jbm.82019030910.1002/jbm.820190309 ↗
2. 10.1002/jbm.a.3282310.1002/jbm.a.32823 ↗
3. Transformation of borate glasses into biologically useful materials
4. 10.1016/j.jnoncrysol.2007.10.00310.1016/j.jnoncrysol.2007.10.003 ↗
5. 10.1007/s10856-007-3328-710.1007/s10856-007-3328-7 ↗
6. 10.1016/S1359-6454(98)80039-610.1016/S1359-6454(98)80039-6 ↗
7. 10.1142/9789814317351_001310.1142/9789814317351_0013 ↗
8. 10.1161/01.CIR.101.25.291610.1161/01.CIR.101.25.2916 ↗
9. 10.1016/S0168-6445(03)00047-010.1016/S0168-6445(03)00047-0 ↗
10. 10.1378/chest.120.6.205910.1378/chest.120.6.2059 ↗
11. 10.1007/s00132-004-0643-210.1007/s00132-004-0643-2 ↗
12. 10.1111/j.1151-2916.1998.tb02540.x10.1111/j.1151-2916.1998.tb02540.x ↗
13. 10.1002/(SICI)1097-4636(19990915)46:4<549::AID-JBM13>3.0.CO;2-M10.1002/(SICI)1097-4636(19990915)46:4<549::AID-JBM13>3.0.CO;2-M ↗
14. 10.1016/j.bone.2008.10.03910.1016/j.bone.2008.10.039 ↗
15. 10.1007/s10856-007-3053-210.1007/s10856-007-3053-2 ↗
16. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement
17. 10.1016/j.matlet.2007.04.08910.1016/j.matlet.2007.04.089 ↗
18. 10.1016/S0955-2219(03)00303-010.1016/S0955-2219(03)00303-0 ↗
19. Mechanisms for converting bioactive silicate, borate and borosilicate glasses to hydroxyapatite in dilute phosphate solutions
20. 11. Hench L.L. and Greenspan D.C. : Bioglass coated Al2O3 ceramics. U.S. Patent 4,103,002, July 25, 1978.
21. 10.1142/9789814317351_000310.1142/9789814317351_0003 ↗
22. 10.1002/jbm.b.3173510.1002/jbm.b.31735 ↗
23. 10.1053/jvet.1999.021910.1053/jvet.1999.0219 ↗
24. 10.1128/AAC.38.12.280310.1128/AAC.38.12.2803 ↗
25. In vitro evaluation of the antibacterial activity of three different central venous catheters against gram-positive bacteria10.1007/s10096-002-0719-z ↗
26. 10.1016/j.jbiomech.2009.01.01610.1016/j.jbiomech.2009.01.016 ↗
27. 10.1016/0142-9612(95)91123-G10.1016/0142-9612(95)91123-G ↗
28. 10.1098/rsif.2009.050410.1098/rsif.2009.0504 ↗
29. 10.1016/j.biomaterials.2003.10.09410.1016/j.biomaterials.2003.10.094 ↗
30. 10.1007/s10856-006-9220-z10.1007/s10856-006-9220-z ↗
31. 10.1289/ehp.94102s74910.1289/ehp.94102s749 ↗
32. 10.1007/s10853-010-4792-x10.1007/s10853-010-4792-x ↗
33. 10.1007/s10856-008-3419-010.1007/s10856-008-3419-0 ↗
34. 10.1002/jbm.82005061110.1002/jbm.820050611 ↗
35. 10.1046/j.0909-8836..t01-6-.x10.1046/j.0909-8836..t01-6-.x ↗
36. 10.1016/j.biomaterials.2004.05.03010.1016/j.biomaterials.2004.05.030 ↗
37. 34. Walenkamp G.H.I.M. : Gentamicin PMMA beads. A clinical pharmacokinetic and toxicological study. Thesis, University of Nijmegen, The Netherlands, 1983.
38. 10.1016/S0142-9612(00)00264-710.1016/S0142-9612(00)00264-7 ↗